Translations:Biguanide/14/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
(No difference)
|
Latest revision as of 17:13, 12 March 2024
However, in hyperinsulinemia, biguanides can lower fasting levels of insulin in plasma. Their therapeutic uses derive from their tendency to reduce gluconeogenesis in the liver, and, as a result, reduce the level of glucose in the blood. Biguanides also tend to make the cells of the body more willing to absorb glucose already present in the bloodstream, and there again reducing the level of glucose in the plasma.